Realtime | Geld | Brief | Zeit |
---|---|---|---|
2,640 | 2,760 | 13:03 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
10.06. | HAOHAI BIOTEC (06826): ARTICLES OF ASSOCIATION | - | HKEx | ||
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
10.06. | HAOHAI BIOTEC (06826): WORKING RULES OF THE NOMINATION COMMITTEE OF THE BOARD | - | HKEx | ||
10.06. | HAOHAI BIOTEC (06826): WORKING RULES OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD | - | HKEx | ||
10.06. | HAOHAI BIOTEC (06826): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 1 | HKEx | ||
10.06. | HAOHAI BIOTEC (06826): WORKING RULES OF THE AUDIT COMMITTEE OF THE BOARD | - | HKEx | ||
10.06. | HAOHAI BIOTEC (06826): ELECTION OF CHAIRMAN OF THE BOARD; CHANGE OF COMPOSITION OF BOARD COMMITTEES AND APPOINTMENT OF SENIOR MANAGEMENT AND SECURITIES ... | 1 | HKEx | ||
10.06. | HAOHAI BIOTEC (06826): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED) | 2 | HKEx | ||
10.06. | HAOHAI BIOTEC (06826): POLL RESULTS OF ANNUAL GENERAL MEETING, A SHAREHOLDERS' CLASS MEETING AND H SHAREHOLDERS' CLASS MEETING; 2024 PROFIT DISTRIBUTION; ... | 1 | HKEx | ||
27.05. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED) | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND THE ABOLISHMENT OF THE SUPERVISORY COMMITTEE | 1 | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): ELECTION OF NEW SESSION OF THE BOARD AND RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): FORM OF PROXY FOR THE 2025 FIRST H SHAREHOLDERS' CLASS MEETING TO BE HELD ON TUESDAY, 10 JUNE 2025 | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): FORM OF PROXY FOR THE 2024 ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 10 JUNE 2025 | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): NOTICE OF 2025 FIRST H SHAREHOLDERS' CLASS MEETING | - | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): NOTICE OF 2024 ANNUAL GENERAL MEETING | 1 | HKEx | ||
09.05. | HAOHAI BIOTEC (06826): CIRCULAR OF 2024 ANNUAL GENERAL MEETING | - | HKEx | ||
07.05. | HAOHAI BIOTEC (06826): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. ANNOUNCEMENT ON THE RECEIPT OF NOTICE OF CASE ... | - | HKEx | ||
06.05. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
28.04. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
VALNEVA | 2,420 | -0,49 % | Valneva überträgt Impfstoffvertrieb in Deutschland an CSL | Valneva SE hat mit CSL Seqirus eine exklusive Vereinbarung über die Vermarktung und den Vertrieb seiner drei Impfstoffe in Deutschland geschlossen. Die Kooperation startet im Juli 2025 mit dem Chikungunya-Impfstoff... ► Artikel lesen | |
AMGEN | 237,00 | +0,11 % | Amgen-Aktie mit Kursverlusten (237,1233 €) | An der US-amerikanischen Börse notiert die Aktie von Amgen derzeit etwas leichter. Der jüngste Kurs betrug 277,19 US-Dollar. An der Börse liegt die Aktie von Amgen zur Stunde im Minus. Das Wertpapier... ► Artikel lesen | |
STRYKER | 334,90 | -0,39 % | Kurs der Stryker-Aktie verharrt auf Vortags-Niveau (324,7763 €) | Am US-amerikanischen Aktienmarkt ist die Stryker-Aktie aktuell unauffällig. Der jüngste Kurs betrug 374,99 US-Dollar. Die Wertschätzung der Börsenteilnehmer für die Aktie von Stryker hat sich heute... ► Artikel lesen | |
REGENERON PHARMACEUTICALS | 444,00 | -0,22 % | Bayer, Regeneron get EU nod for Eylea's label extension | ||
EXACT SCIENCES | 46,740 | +1,95 % | Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care | ||
CSL | 131,64 | +0,41 % | CSL to replace Bavarian Nordic in Valneva's vaccine deal for Germany | ||
CANSINO BIOLOGICS | 3,680 | -0,54 % | CanSino Biologics Inc: CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health | HONG KONG, June 20, 2025 - (ACN Newswire) - Pneumonia is a form of acute respiratory infection, that is common in all age groups and can cause mild to life-threatening illness. It is also the single... ► Artikel lesen | |
BEONE MEDICINES LTD ADR | 206,00 | 0,00 % | BeOne Medicines Ltd.: BeOne Medicines präsentiert wegweisende Onkologie-Pipeline beim R&D Day | Daten zu BRUKINSA, Sonrotoclax, BTK-CDAC und Kombinationstherapien, die den ungedeckten Bedarf von CLL-Patientengruppen umfassend adressieren Vielversprechende neue Daten aus der Pipeline für... ► Artikel lesen | |
BIOMERIEUX | 119,80 | +0,50 % | Dividendenbekanntmachungen (09.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLSTATE CORPORATION US0200021014 1 USD 0,8776 EUR ALPHABET INC CL A US02079K3059 0,21 USD 0,1842 EUR ALPHABET INC CL C US02079K1079 0... ► Artikel lesen | |
SINO BIOPHARM | 0,580 | +1,54 % | SINO BIOPHARM (01177): VOLUNTARY ANNOUNCEMENT - NEW INDICATION OF LM-108 ("CCR8 MONOCLONAL ANTIBODY") INCLUDED IN BREAKTHROUGH THERAPY DESIGNATION PROCESS | ||
ZAI LAB LTD ADR | 31,600 | +6,04 % | ZAI LAB (09688): RESIGNATION OF JOINT COMPANY SECRETARY AND CHANGE OF AUTHORISED REPRESENTATIVE | ||
CSTONE PHARMACEUTICALS | 0,450 | -5,46 % | CSTONE PHARMA-B (02616): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE | ||
CASI PHARMACEUTICALS | 1,210 | -6,92 % | CASI Pharmaceuticals Provides Business and Clinical Update | BEIJING, CHINA / ACCESS Newswire / May 19, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing... ► Artikel lesen | |
3SBIO | 2,360 | -4,84 % | UBS initiates 3SBio stock with Buy rating on Pfizer licensing deal | ||
GENSCRIPT BIOTECH | 1,634 | +3,19 % | GenScript Biotech Corporation Reports FY 2024 Results | Strategic deconsolidation of Legend Biotech unlocked significant value, while core businesses experienced rapid growth.
PISCATAWAY, N.J., March 12, 2025 /PRNewswire/... ► Artikel lesen |